Medical Solutions expands genomics offerings with Autogen buy
This article was originally published in Clinica
In a move to expand its molecular diagnostics business, UK Medical Solutions has conditionally agreed to acquire Autogen Bioclear in an all-cash deal worth up to £6m ($12m). Calne, Wiltshire-based Autogen distributes diagnostic kits, antibodies, DNA clones and other products for genetic testing to the academic and charitably-funded research sectors. The company, which has nine employees, posted a turnover of £2.7m (+10%) for fiscal 2007, while pre-tax profits were up 47% at £823,000. Medical Solutions, based in Nottingham, said the acquisition would present cross-selling opportunities and cost savings, among other benefits.
You may also be interested in...
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
After almost a year as CEO of Centrient, Rex Clements reflects on the company’s experiences operating amid a pandemic that has underlined the importance of a diversified supply chain, while also highlighting the firm’s sustainable manufacturing initiatives and calling for non-price criteria to be taken into account by procurement processes, in an exclusive interview with Generics Bulletin.